Chong Kun Dang Pharmaceutical (185750) — Long-term Investment Intensity
Chong Kun Dang Pharmaceutical (185750) has a Long-term Investment Intensity of 3.1% as of December 2019. Long-term investments of ₩25.09 Billion represent 3.1% of total assets of ₩801.35 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check 185750 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Chong Kun Dang Pharmaceutical Long-term Investment Intensity (2016–2019)
This chart shows how Chong Kun Dang Pharmaceutical's Long-term Investment Intensity has evolved across 4 annual periods from 2016 to 2019. As of December 2019, the intensity stands at 3.1%, reflecting long-term investments of ₩25.09 Billion against total assets of ₩801.35 Billion KRW. For the complete balance sheet picture, see how large is Chong Kun Dang Pharmaceutical's balance sheet.
Annual Long-term Investment Intensity for Chong Kun Dang Pharmaceutical (2016–2019)
The table below presents the year-by-year Long-term Investment Intensity for Chong Kun Dang Pharmaceutical from 2016 to 2019, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read 185750 total debt and obligations for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (KRW) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 3.1% | ₩25.09 Billion | ₩801.35 Billion | ▼ -0.4 pp |
| 2018 | 3.5% | ₩24.83 Billion | ₩711.49 Billion | ▲ +0.9 pp |
| 2017 | 2.6% | ₩17.84 Billion | ₩677.21 Billion | ▼ -0.3 pp |
| 2016 | 2.9% | ₩18.51 Billion | ₩641.70 Billion | — |